Trial Profile
Phase II Study of RAD001 in Advanced Cholangiocarcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- Acronyms RADiChol
- 12 Mar 2018 Status changed to completed, according to results published in the British Journal of Cancer.
- 12 Mar 2018 Primary endpoint (Disease control rate (DCR) at 12 weeks) has not been met, according to results published in the British Journal of Cancer.
- 12 Mar 2018 Results published in the British Journal of Cancer.